Market closedNon-fractional

QIAGEN/QGEN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About QIAGEN

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).

Ticker

QGEN

Sector

Healthcare

Trading on

NYSE

Industry

Life Sciences Tools and Services

Headquarters

Venlo, Netherlands

Employees

5,900

QIAGEN Metrics

BasicAdvanced
$9.4B
Market cap
28.04
P/E ratio
$1.50
EPS
0.42
Beta
-
Dividend rate
$9.4B
0.42
1.844
1.224
26.905
43.31
8.95%
4.56%
9.41%
28.042
4.83
2.6
14.41
26.167
-2.99%
-5.25%
-2.09%
-8.69%

What the Analysts think about QIAGEN

Analyst Ratings

Majority rating from 19 analysts.
Hold

QIAGEN Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
19.17% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$509M
7.00%
Net income
$98M
25.45%
Profit margin
19.17%
17.25%

QIAGEN Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 4.83%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.53
$0.52
$0.55
$0.46
-
Expected
$0.52
$0.50
$0.55
$0.44
$0.52
Surprise
1.14%
3.47%
-0.26%
4.83%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for QIAGEN stock?

QIAGEN (QGEN) has a market cap of $9.4B as of July 14, 2024.

What is the P/E ratio for QIAGEN stock?

The price to earnings (P/E) ratio for QIAGEN (QGEN) stock is 28.04 as of July 14, 2024.

Does QIAGEN stock pay dividends?

No, QIAGEN (QGEN) stock does not pay dividends to its shareholders as of July 14, 2024.

When is the next QIAGEN dividend payment date?

QIAGEN (QGEN) stock does not pay dividends to its shareholders.

What is the beta indicator for QIAGEN?

QIAGEN (QGEN) has a beta rating of 0.42. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell QIAGEN stock

Buy or sell QIAGEN stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing